Faculty of Medicine
Department of Molecular Genetics
Since its inception in 1969, the Department of Molecular Genetics has produced cutting edge research that has had a major impact in academia and the private sector.
World-class faculty and students in the Molecular Genetics community have an outstanding track record with seminal discoveries in a phenomenal breadth of research areas. Their work is transforming how we understand the genetic basis of human disease and creating new opportunities to tackle drug resistance, thwart infectious disease, heal wounds, regenerate tissues, and treat diverse diseases such as cancer, diabetes, Parkinson’s, Alzheimer’s and cardiovascular disease.
There is an urgent need to accelerate the impact of biomedical research on health and quality of life worldwide. The impact of genetics and genomics research on medical practice is increasing at an exponential pace, and now offers a promising path to the discovery of disease vulnerabilities and to the design of effective therapeutics.
To accelerate the potential impact of genomics research on human health, we have created the Department of Molecular Genetics Catalyst Fund Program to seed and accelerate research, and subsequently the opportunity for substantive advance in critical areas of modern genomic science. This strategic investment will help place exceptional innovation and discovery on a path that will allow for the development of new diagnostics, discovery of new drugs and/or more effective therapeutics that will have profound impact on human health.